Title:
A constituent and a method for the medical treatment of inflammatory bowel disease
Document Type and Number:
Japanese Patent JP6202287
Kind Code:
B2
Abstract:
The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II; and methods for treating or preventing inflammatory bowel disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of gastrointestinal diseases and inflammation such as inflammatory bowel disease, ulcerative colitis, mild-to-moderate Crohn's disease, rheumatoid arthritis, inflammatory arthritis, psoriatic arthritis, liver cirrhosis and idiopathic urticaria.
Inventors:
Candula, Mahesh
Application Number:
JP2015513318A
Publication Date:
September 27, 2017
Filing Date:
May 15, 2013
Export Citation:
Assignee:
Celix Bio Private Limited
International Classes:
C07C233/54; A61K31/185; A61K31/20; A61K31/202; A61K31/235; A61K31/655; A61P1/04; A61P1/16; A61P17/06; A61P19/02; A61P29/00; C07C233/55; C07C251/84
Domestic Patent References:
| JP62501703A | ||||
| JP2011527691A | ||||
| JP2008542209A | ||||
| JP48026794A | ||||
| JP59190995A | ||||
| JP59219268A |
Foreign References:
| US20060270635 | ||||
| WO2006125293A1 | ||||
| CN101182298A |
Other References:
ChemMedChem,2008年,Vol.3,p.1956-1964
Attorney, Agent or Firm:
▲吉▼川 俊雄
Kana Ichikawa
Kana Ichikawa
Previous Patent: A lighting installation for automobile headlights
Next Patent: The lighting module for cars
Next Patent: The lighting module for cars